{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-26-000006","form_type":"8-K","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.789761+00:00","generated_at":"2026-05-16T05:04:08.414861+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"GE HealthCare Q4 revenue up 7.1% to $5.7B; 2026 EPS guidance $4.95-$5.15","bullets":["Q4 revenue $5.7B (+7.1% YoY, organic +4.8%); diluted EPS $1.29, adjusted EPS $1.44.","Full year revenue $20.6B (+4.8%); diluted EPS $4.55, adjusted EPS $4.59; free cash flow $1.5B.","2026 guidance: organic revenue growth 3-4%, adj. EPS $4.95-$5.15, adj. EBIT margin 15.8-16.1%.","Q4 net income $589M vs $720M prior; margins compressed due to tariff expense and unfavorable mix.","Acquiring Intelerad for $2.3B, expected close H1 2026; closed Nihon Medi-Physics and icometrix in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-26-000006","json":"https://secwatch.observer/filing/0001932393-26-000006.json","markdown":"https://secwatch.observer/filing/0001932393-26-000006.md","text":"https://secwatch.observer/filing/0001932393-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239326000006/0001932393-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239326000006/gehc-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:04:08.414861+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}